Liver Adenosine Monophosphate-Activated Kinase-α2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin
Fabrizio Andréelli(Centre National de la Recherche Scientifique), Benoı̂t Viollet(Centre National de la Recherche Scientifique), Rémy Burcelin(Inserm), Christophe Perrin(META Group), Marc Foretz(Centre National de la Recherche Scientifique), Claude Knauf(Université Toulouse III - Paul Sabatier), Patrice D. Cani(Walloon Excellence in Lifesciences and Biotechnology), Bruno Pillot(Inserm), François Tronche(Collège de France), Miguel A. Iglesias(Université Toulouse III - Paul Sabatier), André Bado(Inserm), Sophie Vaulont(Centre National de la Recherche Scientifique), Gilles Mithieux(Université Claude Bernard Lyon 1)
Cited by 229
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Metformin: From Mechanisms of Action to Therapies
|Cell Metabolism|2014|1.5k
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation
|Journal of Clinical Investigation|2002|1.4k
Human gut microbiome: hopes, threats and promises
|Gut|2018|1.4k